A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer

BACKGROUND: Epithelial growth factor receptor inhibitors (EGFRis) and bevacizumab (BEV) are used in combination with chemotherapy for the treatment of metastatic colorectal cancer (mCRC). However, few randomized controlled trials (RCTs) have directly compared their relative efficacy on progression-f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumachev, Alexander, Yan, Marie, Berry, Scott, Ko, Yoo-Joung, Martinez, Maria C. R., Shah, Keya, Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608731/
https://www.ncbi.nlm.nih.gov/pubmed/26474403
http://dx.doi.org/10.1371/journal.pone.0140187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608731/
https://www.ncbi.nlm.nih.gov/pubmed/26474403
http://dx.doi.org/10.1371/journal.pone.0140187

Ejemplares similares